PURPOSE: We sought to determine whether an early CT ischemic lesion showing parenchymal hypoattenuation might be undetectable on diffusion-weighted imaging (DWI) in acute cerebral ischemia. MATERIALS AND METHODS: We retrospectively evaluated CT and MR images of 70 consecutive patients with acute middle cerebral artery (MCA) infarction. All patients underwent CT and MR imaging within 6 hours of symptom onset. We determined the presence of reversed discrepancy (RD), defined as an early ischemic lesion showing parenchymal hypoattenuation on CT but no hyperintensity on DWI. CT Hounsfield units (HU), apparent diffusion coefficients (ADCs), and perfusion parameters were calculated for RD lesions. RESULTS: RD was found in 9 (12.9%) patients and at basal ganglia (89%). The mean HU of RD lesion was lower than that of normal tissue (DeltaHU, 2.33 +/- 0.74, P < .001). RD lesions showed no significant decrease of ADC (ADC ratio, 0.97 +/- 0.07, P = .059) and cerebral blood flow (relative CBF, 0.87 +/- 0.20, P > 0.05). Delayed DWI hyperintensity occurred in 8 (88.8%) RD lesions, and all lesions progressed to infarction. In 6 (66%) of 9 patients with RD, Alberto Stroke Program Early CT scores of ischemic lesions were lower on CT than those on DWI. CONCLUSION: RD was uncommonly found mainly in basal ganglia, and all RD lesions progressed to infarction at follow-up. Early CT ischemic lesion showing parenchymal hypoattenuation may be undetectable on DWI, and DWI may underestimate extent of severe ischemic tissue in patients with acute MCA infarction.
PURPOSE: We sought to determine whether an early CT ischemic lesion showing parenchymal hypoattenuation might be undetectable on diffusion-weighted imaging (DWI) in acute cerebral ischemia. MATERIALS AND METHODS: We retrospectively evaluated CT and MR images of 70 consecutive patients with acute middle cerebral artery (MCA) infarction. All patients underwent CT and MR imaging within 6 hours of symptom onset. We determined the presence of reversed discrepancy (RD), defined as an early ischemic lesion showing parenchymal hypoattenuation on CT but no hyperintensity on DWI. CT Hounsfield units (HU), apparent diffusion coefficients (ADCs), and perfusion parameters were calculated for RD lesions. RESULTS: RD was found in 9 (12.9%) patients and at basal ganglia (89%). The mean HU of RD lesion was lower than that of normal tissue (DeltaHU, 2.33 +/- 0.74, P < .001). RD lesions showed no significant decrease of ADC (ADC ratio, 0.97 +/- 0.07, P = .059) and cerebral blood flow (relative CBF, 0.87 +/- 0.20, P > 0.05). Delayed DWI hyperintensity occurred in 8 (88.8%) RD lesions, and all lesions progressed to infarction. In 6 (66%) of 9 patients with RD, Alberto Stroke Program Early CT scores of ischemic lesions were lower on CT than those on DWI. CONCLUSION: RD was uncommonly found mainly in basal ganglia, and all RD lesions progressed to infarction at follow-up. Early CT ischemic lesion showing parenchymal hypoattenuation may be undetectable on DWI, and DWI may underestimate extent of severe ischemic tissue in patients with acute MCA infarction.
Authors: Assia Jaillard; Marc Hommel; Alison E Baird; Italo Linfante; Rafael H Llinas; Louis R Caplan; Robert R Edelman; Steven Warach Journal: Cerebrovasc Dis Date: 2002 Impact factor: 2.762
Authors: M E Moseley; Y Cohen; J Mintorovitch; L Chileuitt; H Shimizu; J Kucharczyk; M F Wendland; P R Weinstein Journal: Magn Reson Med Date: 1990-05 Impact factor: 4.668
Authors: Fuhai Li; Kai-Feng Liu; Matthew D Silva; Xiangjun Meng; Tibo Gerriets; Karl G Helmer; Joseph D Fenstermacher; Christopher H Sotak; Marc Fisher Journal: AJNR Am J Neuroradiol Date: 2002-02 Impact factor: 3.825
Authors: Mark W Parsons; P Alan Barber; Jonathon Chalk; David G Darby; Stephen Rose; Patricia M Desmond; Richard P Gerraty; Brian M Tress; Peter M Wright; Geoffrey A Donnan; Stephen M Davis Journal: Ann Neurol Date: 2002-01 Impact factor: 10.422
Authors: K G Rieth; K Fujiwara; G Di Chiro; I Klatzo; R A Brooks; G S Johnston; C M O'Connor; L G Mitchell Journal: Radiology Date: 1980-05 Impact factor: 11.105
Authors: W Hacke; M Kaste; C Fieschi; R von Kummer; A Davalos; D Meier; V Larrue; E Bluhmki; S Davis; G Donnan; D Schneider; E Diez-Tejedor; P Trouillas Journal: Lancet Date: 1998-10-17 Impact factor: 79.321
Authors: J B Fiebach; P D Schellinger; O Jansen; M Meyer; P Wilde; J Bender; P Schramm; E Jüttler; J Oehler; M Hartmann; S Hähnel; M Knauth; W Hacke; K Sartor Journal: Stroke Date: 2002-09 Impact factor: 7.914
Authors: A Z Copelan; E R Smith; G T Drocton; K H Narsinh; D Murph; R S Khangura; Z J Hartley; A A Abla; W P Dillon; C F Dowd; R T Higashida; V V Halbach; S W Hetts; D L Cooke; K Keenan; J Nelson; D Mccoy; M Ciano; M R Amans Journal: AJNR Am J Neuroradiol Date: 2020-11-19 Impact factor: 3.825